Get early access! Join the Twelve Data AI Assistant waitlist now.

LPGO

OMX
Market closed
Access this stock data via API
Subscribe
Lipigon Pharmaceuticals AB
0
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 10.3M 16.4M 0 3.2M
Cost of revenue
Gross profit
Operating expense
Research & development
Selling general and admin 31.7M 38.2M
Other operating expenses 29.3M 22.4M 32.0M 38.9M
Operating income -25.6M -12.4M -37.7M -41.2M
Non operating interest income
Income 376K 246K 37K 83K
Expense 63K 3K 0 5K
Other income expense
Pretax income -25.3M -12.1M -37.7M -41.1M
Tax provision 0 0 0 0
Net income -25.3M -12.1M -37.7M -41.1M
Basic EPS -0.1 -0.2 -2.1 -3.3
Diluted EPS -0.1 -0.2 -2.1 -3.4
Basic average shares 180.3M 64.1M 17.8M 12.3M
Diluted average shares 180.3M 64.1M 17.8M 12.3M
EBITDA -25.1M -12.1M -37.7M -41.1M
Net income from continuing op. -25.6M -12.4M -37.7M -41.2M
Minority interests
Preferred stock dividends 0 0 0 0
Market closed

Exchange is currently closed
Main market opens in 7 hours 18 minutes

01:41
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CEST, UTC+02:00).